Novolin N Innolet
"Nov. 15, 2012 -- The number of people diagnosed with diabetes in the U.S. jumped by 50% or more in 42 states and by more than 100% in 18 of those states in just under two decades, according to the latest snapshot from the CDC.
Novolin N Innolet
Novolin N Innolet Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Novolin N InnoLet [NPH, Human Insulin Isophane Suspension (recombinant DNA origin)] is a form of insulin, a hormone produced in the body, used to treat diabetes. This medication is available over-the-counter. Common side effects include localized reactions such as red, swollen and itchy skin where the insulin has been injected.
Novolin N is commonly known as NPH, Human Insulin Isophane Suspension (recombinant DNA origin). The concentration of this product is 100 units of insulin per milliliter. Novolin N InnoLet may interact with albuterol, clonidine, reserpine, guanethidine, or beta-blockers. Tell your doctor all medications and supplements you use. Consult your doctor to discuss the best way to manage your diabetes while you are pregnant or breastfeeding.
Our Novolin N InnoLet [NPH, Human Insulin Isophane Suspension (recombinant DNA origin)] Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Novolin N Innolet in Detail - Patient Information: Side Effects
Get emergency medical help if you have any of these signs of insulin allergy: itching skin rash over the entire body, wheezing, trouble breathing, fast heart rate, sweating, or feeling like you might pass out.
Hypoglycemia, or low blood sugar, is the most common side effect of insulin isophane. Symptoms of low blood sugar may include headache, nausea, hunger, confusion, drowsiness, weakness, dizziness, blurred vision, fast heartbeat, sweating, tremor, trouble concentrating, confusion, or seizure (convulsions). Watch for signs of low blood sugar. Carry a piece of non-dietetic hard candy or glucose tablets with you in case you have low blood sugar.
Tell your doctor if you have itching, swelling, redness, or thickening of the skin where you inject insulin isophane.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Novolin N Innolet (NPH, Human Insulin Isophane Suspension 3 ml Disposable Prefilled Syringe)
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Novolin N Innolet FDA Prescribing Information: Side Effects
A few people with diabetes develop red, swollen and itchy skin where the insulin has been injected. This is called a "local reaction" and it may occur if the injection is not properly made, if the skin is sensitive to the cleansing solution, or if you are allergic to the insulin being used. If you have a local reaction, tell your physician.
Generalized insulin allergy occurs rarely, but when it does it may cause a serious reaction, including skin rash over the body, shortness of breath, fast pulse, sweating, and a drop in blood pressure. If any of these symptoms develop, you should seek emergency medical care. If severe allergic reactions to insulin have occurred (i.e., generalized rash, swelling or breathing difficulties) you should be skin-tested with each new insulin preparation before it is used.
Read the entire FDA prescribing information for Novolin N Innolet (NPH, Human Insulin Isophane Suspension 3 ml Disposable Prefilled Syringe)
Additional Novolin N Innolet Information
Report Problems to the Food and Drug Administration
Find tips and advances in treatment.